Gerhard Heil

10.9k total citations · 3 hit papers
122 papers, 6.8k citations indexed

About

Gerhard Heil is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gerhard Heil has authored 122 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Hematology, 34 papers in Molecular Biology and 32 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gerhard Heil's work include Acute Myeloid Leukemia Research (78 papers), Acute Lymphoblastic Leukemia research (32 papers) and Hematopoietic Stem Cell Transplantation (24 papers). Gerhard Heil is often cited by papers focused on Acute Myeloid Leukemia Research (78 papers), Acute Lymphoblastic Leukemia research (32 papers) and Hematopoietic Stem Cell Transplantation (24 papers). Gerhard Heil collaborates with scholars based in Germany, Austria and United Kingdom. Gerhard Heil's co-authors include Arnold Ganser, Jürgen Krauter, Hartmut Döhner, Brigitte Schlegelberger, Konstanze Döhner, Dieter Hoelzer, Michael Morgan, Axel Benner, Wolfram Brugger and Richard F. Schlenk and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Gerhard Heil

117 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

2008 1.1k citations Richard F. Schlenk, Konstanze Döhner et al. New England Journal of Medicine profile →
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

2013 962 citations Mathias Rummel, N. Niederle et al. The Lancet profile →
Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults

1988 430 citations D. Hoelzer, Th. Büchner et al. profile →

Peers

Countries citing papers authored by Gerhard Heil

Since Specialization

Citations

This map shows the geographic impact of Gerhard Heil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Heil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Heil more than expected).

Fields of papers citing papers by Gerhard Heil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerhard Heil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Heil. The network helps show where Gerhard Heil may publish in the future.

Co-authorship network of co-authors of Gerhard Heil

This figure shows the co-authorship network connecting the top 25 collaborators of Gerhard Heil. A scholar is included among the top collaborators of Gerhard Heil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerhard Heil. Gerhard Heil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial breakdown → 2013 ·The Lancet ·Mathias Rummel, N. Niederle, Georg Maschmeyer, Gamal-Andre Banat, Ulrich von Grünhagen, Christoph Losem, Dorothea Kofahl-Krause, Gerhard Heil, Manfred Welslau, Christina Balser, Ulrich Kaiser, Eckhart Weidmann, Heinz Dürk, Harald Balló, Martina Stauch, Fritz Roller, Juergen Barth, Dieter Hoelzer, Axel Hinke, Wolfram Brugger	962
2	Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia breakdown → 2008 ·New England Journal of Medicine ·Richard F. Schlenk, Konstanze Döhner, Jürgen Krauter, Stefan Fröhling, Andrea Corbacioglu, Lars Bullinger, Marianne Habdank, Daniela Späth, Michael Morgan, Axel Benner, Brigitte Schlegelberger, Gerhard Heil, Arnold Ganser, Hartmut Döhner	1103
3	Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia 2004 ·Annals of Hematology ·W.-K. Hofmann, Gerhard Heil, (unknown), Stephanie A. Wiebe, Oliver G. Ottmann, Lothar Bergmann, Klaus Hoeffken, J. Th. Fischer, Alexander Knuth, Karin Kolbe, Hans‐Joachim Schmoll, Wolfgang Langer, M. Westerhausen, (unknown), D. Hoelzer, Arnold Ganser	44
4	Risk-adapted induction and consolidation therapy in adults with de novo AML aged =�60�years: results of a prospective multicenter trial 2004 ·Annals of Hematology ·Gerhard Heil, J Krauter, A. Raghavachar, Lothar Bergmann, D. Hoelzer, Walter Fiedler, (unknown), L. Noens, Günter Schlimok, R. Arnold, Hartmut Kirchner, Arnold Ganser	42
5	Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia 2004 ·Leukemia ·Carsten Müller‐Tidow, (unknown), Horst Buerger, Jens Packeisen, (unknown), Gerhard Heil, (unknown), (unknown), Joachim Schwäble, Björn Steffen, WD Ludwig, Achim Heinecke, Th. Büchner, Wolfgang E. Berdel, Hubert Serve	24
6	Evidence for allelic evolution of C/EBPalpha mutations in acute myeloid leukaemia 2003 ·British Journal of Haematology ·Jens Tiesmeier, Andreas Czwalinna, Carsten Müller‐Tidow, Jürgen Krauter, Hubert Serve, Gerhard Heil, Arnold Ganser, Walter Verbeek	35
7	Analysis of the Nuclear Distribution of the Translocation t(8;21)-Derived Fusion Protein AML1/ETO by Confocal Laser Scanning Microscopy 2002 ·Journal of Hematotherapy & Stem Cell Research ·Stefan Nagel, Lothar Hambach, Jürgen Krauter, (unknown), Olaf Heidenreich, Arnold Ganser, Gerhard Heil	3
8	Receptor-Mediated Endocytosis of CD34 on Hematopoietic Cells after Stimulation with the Monoclonal Antibody Anti-HPCA-1 2001 ·Journal of Hematotherapy & Stem Cell Research ·Jürgen Krauter, (unknown), Lothar Hambach, Anke Kohlenberg, Eberhard Gunsilius, Arnold Ganser, Gerhard Heil	3
9	Cleavage of AML1/MTG8 by asymmetric hammerhead ribozymes 2001 ·European Journal of Biochemistry ·(unknown), (unknown), Heidemarie Riehle, Alfred Nordheim, Jürgen Krauter, Stefan Nagel, Gerhard Heil, Olaf Heidenreich	8
10	Real‐time RT‐PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)‐positive AML patients 1999 ·British Journal of Haematology ·Jürgen Krauter, Mike P. Wattjes, Stefan Nagel, Olaf Heidenreich, Utz Krug, (unknown), Donald Bunjes, Lothar Bergmann, Arnold Ganser, Gerhard Heil	54
11	Results of a randomised, double-blind placebo controlled phase III study of filgrastim in remission induction and early consolidation therapy for adults with de-novo acute myeloid leukemia 1995 ·Ghent University Academic Bibliography (Ghent University) ·Gerhard Heil, Miguel Á. Sanz, Klaus Lechner, Jun Yin, L. Noens, (unknown), Jcm Ho, D. Hoelzer, Chris O’Brien, James Matcham, Alan Barge	12
12	High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia 1995 ·Annals of Hematology ·Gerhard Heil, Paris S. Mitrou, D. Hoelzer, Mathias Freund, H. Link, Gerhard Ehninger, B. Steinke, (unknown), H. Wandt, (unknown), (unknown), (unknown), W. Queißer, B. Löffler, (unknown), Josef Högel, H. Heimpel, (unknown)	8
13	Peroxidase Expression in Acute Unclassified Leukemias: Ultrastructural Studies in Combination with Immunophenotyping 1994 ·Leukemia & lymphoma ·Gerhard Heil, Eberhard Gunsilius, D. Hoelzer, (unknown), (unknown)	2
14	Acute lymphoblastic leukemia in patients over 59 years of age 1994 ·Annals of Hematology ·(unknown), Gerhard Heil, H. Heimpel	25
15	Simultaneous administration of granulocyte colony-stimulating factor (Filgrastim) and induction chemotherapy in acute lymphoblastic leukemia 1993 ·Annals of Hematology ·Oliver G. Ottmann, Arnold Ganser, Mathias Freund, Gerhard Heil, Wolfgang Hiddemann, W. Heit, (unknown), D. Hoelzer	15
16	Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia — initial results 1993 ·Annals of Hematology ·Arnold Ganser, Gerhard Heil, Karin Kolbe, Georg Maschmeyer, J.-Th. Fischer, Lothar Bergmann, P.S. Mitrou, W. Heit, H. Heimpel, Christoph Huber, (unknown)	23
17	Idarubicin, Cytosine Arabinoside and Etoposide for Relapsed or Refractory Acute Myeloid Leukemia 1992 ·Oncology Research and Treatment ·Gerhard Heil, Donald Bunjes, R. Arnold, Matthias Goebel, (unknown), E. Kurrle	3
18	Consolidation Therapy with High-Dose Cytosine Arabinoside: Experiences of a Prospective Study in Acute Myeloid Leukemia 1990 ·Hämatologie und Bluttransfusion ·E. Kurrle, Gerhard Ehninger, (unknown), M. Freund, Gerhard Heil, D. Hoelzer, Hartmut Link, B. Löffler, (unknown), P.S. Mitrou, (unknown), W. Queißer, (unknown), H. Wandt	4
19	Induktions- und intensivierte Konsolidationstherapie der akuten myeloischen Leukämie des Erwachsenen 1988 ·Oncology Research and Treatment ·E. Kurrle, Gerhard Ehninger, Mathias Freund, Gerhard Heil, D. Hoelzer, Hartmut Link, P.S. Mitrou, (unknown), W. Queißer, Günter Schlimok, H. Wandt	1
20	Age Adapted Induction and Intensified Consolidation Therapy in Acute Myelogenous Leukemia 1986 ·Oncology Research and Treatment ·E. Kurrle, Gerhard Ehninger, Mathias Freund, Gerhard Heil, D. Hoelzer, H. Link, P.S. Mitrou	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact